A Phase II Trial of Poly-ICLC for Progressive, Previously Treated Low-Grade Gliomas in Children and Young Adults With Neurofibromatosis Type 1

Conditions:   NF1;   Low-grade Glioma Intervention:   Drug: Poly ICLC Sponsors:   University of Alabama at Birmingham;   Children's Healthcare of Atlanta;   Children's Hospital Los Angeles Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials